Literature DB >> 30355113

Microstructural Damage in Normal-Appearing Brain Parenchyma and Neurocognitive Dysfunction in Adult Moyamoya Disease.

Shoko Hara1,2, Masaaki Hori2, Syo Murata2, Ryo Ueda2,3, Yoji Tanaka1, Motoki Inaji1, Taketoshi Maehara1, Shigeki Aoki2, Tadashi Nariai1.   

Abstract

Background and Purpose -Microstructural damage in the brain induced by chronic ischemia is suggested to play a pivotal role in the neurocognitive dysfunction of adults with Moyamoya disease (MMD). We investigated specific changes in the brain microstructure and their correlations with neurocognitive dysfunction in patients with MMD using a multishell diffusion magnetic resonance imaging technique called neurite orientation dispersion and density imaging. Methods- We evaluated 26 patients with MMD (16-63 years old, 20 females) and 20 age- and sex-matched normal volunteers using neurite orientation dispersion and density imaging and neuropsychological batteries. Neurite orientation dispersion and density imaging calculates 2 parameters: the intracellular volume fraction (Vic), which reflects the axon density in the white matter and dendrite density in the cortex, and the orientation dispersion index (OD), which reflects the network complexity. The microstructural damage and its correlation with neurocognitive performance were evaluated by performing a whole-brain analysis using SPM12 and correlation analysis with regional values. Results- Patients with MMD had significantly lower Vic in the white matter and a lower OD mainly in the cortex than those of the controls ( P<0.001, family-wise error corrected). Of all neuropsychological scores, Processing Speed Index (PS) exhibited the strongest correlation with Vic in the white matter ( P<0.001, family-wise error corrected). The Vic and OD values for regions with group differences, including both temporoparietal and frontal areas, correlated with neurocognitive performance (absolute r=0.37-0.64; P<0.01). Conclusions- Chronic ischemia in MMD may decrease the axon density in the white matter and dendrite density in the cortex (Vic) and simplify network complexity (OD), leading to neurocognitive dysfunction. Processing Speed Index may be the most sensitive index used to evaluate the ischemic burden, and the posterior part of the brain may play an important role in neurocognitive function. Clinical Trial Registration- URL: http://www.umin.ac.jp/ctr/ . Unique identifier: UMIN000023082.

Entities:  

Keywords:  Moyamoya disease; brain ischemia; cerebrovascular disorders; cognition; cognitive dysfunction; diffusion magnetic resonance imaging; magnetic resonance imaging

Mesh:

Year:  2018        PMID: 30355113     DOI: 10.1161/STROKEAHA.118.022367

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

1.  Myelin and Axonal Damage in Normal-Appearing White Matter in Patients with Moyamoya Disease.

Authors:  S Hara; M Hori; A Hagiwara; Y Tsurushima; Y Tanaka; T Maehara; S Aoki; T Nariai
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-27       Impact factor: 3.825

2.  MR Diffusional Kurtosis Imaging-Based Assessment of Brain Microstructural Changes in Patients with Moyamoya Disease before and after Revascularization.

Authors:  P-G Qiao; X Cheng; G-J Li; P Song; C Han; Z-H Yang
Journal:  AJNR Am J Neuroradiol       Date:  2020-01-23       Impact factor: 3.825

3.  Intravoxel incoherent motion perfusion in patients with Moyamoya disease: comparison with 15O-gas positron emission tomography.

Authors:  Shoko Hara; Masaaki Hori; Ryo Ueda; Akifumi Hagiwara; Shihori Hayashi; Motoki Inaji; Yoji Tanaka; Taketoshi Maehara; Kenji Ishii; Shigeki Aoki; Tadashi Nariai
Journal:  Acta Radiol Open       Date:  2019-05-23

4.  Beneficial Effect of Carotid Artery Stenting on Cerebral Hemodynamic Impairment and Cognitive Function.

Authors:  Shoko Hara; Mitsuru Seida; Kotaro Kumagai; Takahiro Yamamoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2019-11-21       Impact factor: 1.742

5.  Assessment of risk factors for postoperative cognitive dysfunction after coronary artery bypass surgery: a single-center retrospective cohort study.

Authors:  Yongtao Sun; Hai Feng; Ting Zou; Ming Hou; Yanwu Jin; Changping Gu; Yuelan Wang; Juan Li; Mengjie Liu; Min Zhang; Yalei Gao
Journal:  Biosci Rep       Date:  2021-02-26       Impact factor: 3.840

6.  Moyamoya disease: A human model for chronic hypoperfusion and intervention in Alzheimer's disease.

Authors:  Xiang Zou; Yifan Yuan; Yujun Liao; Conglin Jiang; Fan Zhao; Ding Ding; Yuxiang Gu; Liang Chen; Ying-Hua Chu; Yi-Cheng Hsu; Patrick Alexander Liebig; Bin Xu; Ying Mao
Journal:  Alzheimers Dement (N Y)       Date:  2022-04-06

7.  Preoperative brain connectome predicts postoperative changes in processing speed in moyamoya disease.

Authors:  Mengxia Gao; Charlene L M Lam; Wai M Lui; Kui Kai Lau; Tatia M C Lee
Journal:  Brain Commun       Date:  2022-08-20

8.  Pathophysiological Significance of Neutrophilic Transfer RNA-Derived Small RNAs in Asymptomatic Moyamoya Disease.

Authors:  Lingzhi Li; Ping Liu; Rongliang Wang; Yuyou Huang; Jichang Luo; Liqun Jiao; Zhen Tao; Yangmin Zheng; Junfen Fan; Haiping Zhao; Ziping Han; Yumin Luo
Journal:  Cells       Date:  2021-05-01       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.